SG Americas Securities, LLC - ARIAD PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$1,165,000
+140.7%
93,615
+164.5%
0.01%
+100.0%
Q3 2016$484,000
+505.0%
35,389
+181.8%
0.01%
+400.0%
Q1 2016$80,000
-42.9%
12,558
-47.7%
0.00%0.0%
Q3 2015$140,000
-13.6%
24,024
+22.2%
0.00%0.0%
Q1 2015$162,000
-4.7%
19,656
-20.3%
0.00%0.0%
Q4 2014$170,00024,6730.00%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$175,916,00040.51%
Consonance Capital Management LP 8,695,742$119,045,00011.46%
Tamarack Advisers, LP 3,700,000$49,358,0007.76%
Opaleye Management Inc. 1,045,000$14,306,0007.49%
Granite Point Capital Management, L.P. 457,415$6,262,0002.44%
Redmile Group, LLC 2,138,471$29,276,0002.33%
IRONWOOD INVESTMENT MANAGEMENT LLC 206,010$2,820,0002.17%
Palo Alto Investors LP 2,587,617$35,424,0002.06%
PRICE MICHAEL F 940,000$12,869,0001.71%
HighVista Strategies LLC 638,086$8,735,0001.62%
View complete list of ARIAD PHARMACEUTICALS INC shareholders